Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study
Open Access
- 1 July 2020
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical and Translational Gastroenterology
- Vol. 11 (7), e00215
- https://doi.org/10.14309/ctg.0000000000000215
Abstract
Study was to evaluate the association of significantly elevated lipase with disease outcomes. METHODS: Data about demographics, symptoms, laboratory values, and clinical outcomes were collected for 1,003 consecutive patients testing positive for COVID-19. Elevated lipase was defined as greater than 3 times the upper limit of normal (>3 × ULN). Baseline characteristics among patients with or without elevated lipase were compared using Fisher exact test or Student t-test for categorical or numerical variables, respectively. Logistic regression was used to evaluate the association of lipase levels with primary clinical outcomes (intensive care unit admission and intubation) adjusted for age, sex, body mass index, history of diabetes, and hypertension. RESULTS: Of 1,003 patients with COVID-19, 83 had available lipase levels and were all admitted to the hospital. Of 83, 14 (16.8%) had elevated lipase (>3 × ULN), which was associated with higher rates of leukocytosis (P < 0.001) and abnormal liver enzymes (P < 0.01). Compared with lower lipase levels (<3 × ULN), patients with elevated lipase had higher rates of ICU admission (92.9% vs 32.8%; P < 0.001) and intubation (78.6% vs 23.5%; P 0.002). In a multivariable-adjusted model, higher lipase levels were significantly associated with admission to the ICU and rate of intubation. DISCUSSION: Lipase elevation is seen in COVID-19 and is associated with worse disease outcomes....This publication has 18 references indexed in Scilit:
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysisGastroenterology, 2020
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptomsGut, 2020
- Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmissionAlimentary Pharmacology & Therapeutics, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosaInternational Journal of Oral Science, 2020
- Review of Infectious Etiology of Acute PancreatitisGastroenterology Research, 2017
- PANCREATITIS OR NOT? – Elevated lipase and amylase in ICU patientsJournal of Critical Care, 2015
- Significant elevations of serum lipase not caused by pancreatitis: a systematic reviewHPB, 2015
- Treatment of severe acute pancreatitis and its complicationsWorld Journal of Gastroenterology, 2014
- A prospective study of fever in the intensive care unitIntensive Care Medicine, 1999